N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide

C151H222F4N28O30S12 — CID 157498334

About N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide

N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide (PubChem CID 157498334) has the molecular formula C151H222F4N28O30S12 and a molecular weight of 3370.40 g/mol. Its IUPAC name is N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide.

Molecular Properties

• Compound Name: N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide
• PubChem CID: 157498334
• Molecular Formula: C151H222F4N28O30S12
• Molecular Weight: 3370.40 g/mol
• Exact Mass: 3367.33
• IUPAC Name: N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide
• SMILES: CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2ccccc2)cc1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2scnc2c1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2c1Cc1ccccc1-2.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2nsnc12.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ncccn1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ncncn1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1nnc(-c2ccc(F)cc2)s1.COc1cc(NC(=O)CCCCNS(=O)(=O)C(C)(C)C)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)CCCCNS(=O)(=O)C(C)(C)C
• InChI: InChI=1S/C22H28N2O3S.C21H28N2O3S.C18H30N2O6S.C17H25F3N2O3S.C17H23FN4O3S2.C16H23N3O3S2.C15H22N4O3S2.C13H22N4O3S.C12H21N5O3S/c1-22(2,3)28(26,27)23-14-7-6-13-21(25)24-20-12-8-11-18-17-10-5-4-9-16(17)15-19(18)20;1-21(2,3)27(25,26)22-16-8-7-11-20(24)23-19-14-12-18(13-15-19)17-9-5-4-6-10-17;1-18(2,3)27(22,23)19-10-8-7-9-16(21)20-13-11-14(24-4)17(26-6)15(12-13)25-5;1-12-11-13(17(18,19)20)8-9-14(12)22-15(23)7-5-6-10-21-26(24,25)16(2,3)4;1-17(2,3)27(24,25)19-11-5-4-6-14(23)20-16-22-21-15(26-16)12-7-9-13(18)10-8-12;1-16(2,3)24(21,22)18-9-5-4-6-15(20)19-12-7-8-14-13(10-12)17-11-23-14;1-15(2,3)24(21,22)16-10-5-4-9-13(20)17-11-7-6-8-12-14(11)19-23-18-12;1-13(2,3)21(19,20)16-10-5-4-7-11(18)17-12-14-8-6-9-15-12;1-12(2,3)21(19,20)16-7-5-4-6-10(18)17-11-14-8-13-9-15-11/h4-5,8-12,23H,6-7,13-15H2,1-3H3,(H,24,25);4-6,9-10,12-15,22H,7-8,11,16H2,1-3H3,(H,23,24);11-12,19H,7-10H2,1-6H3,(H,20,21);8-9,11,21H,5-7,10H2,1-4H3,(H,22,23);7-10,19H,4-6,11H2,1-3H3,(H,20,22,23);7-8,10-11,18H,4-6,9H2,1-3H3,(H,19,20);6-8,16H,4-5,9-10H2,1-3H3,(H,17,20);6,8-9,16H,4-5,7,10H2,1-3H3,(H,14,15,17,18);8-9,16H,4-7H2,1-3H3,(H,13,14,15,17,18)
• InChIKey: BYCHXSNHIXQJNC-UHFFFAOYSA-N
• XLogP: 25.46
• TPSA: 834.02 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 43
• Rotatable Bonds: 68
• Heavy Atoms: 225
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3370.40
LogP ≤ 5	25.46
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	43

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?

The IUPAC name of N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide (CID 157498334) is N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide.

What is the SMILES notation for N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?

The canonical SMILES for N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide is CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2ccccc2)cc1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2scnc2c1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2c1Cc1ccccc1-2.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2nsnc12.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ncccn1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ncncn1.CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1nnc(-c2ccc(F)cc2)s1.COc1cc(NC(=O)CCCCNS(=O)(=O)C(C)(C)C)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)CCCCNS(=O)(=O)C(C)(C)C.

What is the InChIKey of N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?

The InChIKey is BYCHXSNHIXQJNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H28N2O3S.C21H28N2O3S.C18H30N2O6S.C17H25F3N2O3S.C17H23FN4O3S2.C16H23N3O3S2.C15H22N4O3S2.C13H22N4O3S.C12H21N5O3S/c1-22(2,3)28(26,27)23-14-7-6-13-21(25)24-20-12-8-11-18-17-10-5-4-9-16(17)15-19(18)20;1-21(2,3)27(25,26)22-16-8-7-11-20(24)23-19-14-12-18(13-15-19)17-9-5-4-6-10-17;1-18(2,3)27(22,23)19-10-8-7-9-16(21)20-13-11-14(24-4)17(26-6)15(12-13)25-5;1-12-11-13(17(18,19)20)8-9-14(12)22-15(23)7-5-6-10-21-26(24,25)16(2,3)4;1-17(2,3)27(24,25)19-11-5-4-6-14(23)20-16-22-21-15(26-16)12-7-9-13(18)10-8-12;1-16(2,3)24(21,22)18-9-5-4-6-15(20)19-12-7-8-14-13(10-12)17-11-23-14;1-15(2,3)24(21,22)16-10-5-4-9-13(20)17-11-7-6-8-12-14(11)19-23-18-12;1-13(2,3)21(19,20)16-10-5-4-7-11(18)17-12-14-8-6-9-15-12;1-12(2,3)21(19,20)16-7-5-4-6-10(18)17-11-14-8-13-9-15-11/h4-5,8-12,23H,6-7,13-15H2,1-3H3,(H,24,25);4-6,9-10,12-15,22H,7-8,11,16H2,1-3H3,(H,23,24);11-12,19H,7-10H2,1-6H3,(H,20,21);8-9,11,21H,5-7,10H2,1-4H3,(H,22,23);7-10,19H,4-6,11H2,1-3H3,(H,20,22,23);7-8,10-11,18H,4-6,9H2,1-3H3,(H,19,20);6-8,16H,4-5,9-10H2,1-3H3,(H,17,20);6,8-9,16H,4-5,7,10H2,1-3H3,(H,14,15,17,18);8-9,16H,4-7H2,1-3H3,(H,13,14,15,17,18).

What are the key properties of N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?

N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide has a molecular weight of 3370.40 g/mol, XLogP of 25.46, 68 rotatable bonds, 18 hydrogen bond donors, and 43 hydrogen bond acceptors.

Where does this data come from?

All data for N-(2,1,3-benzothiadiazol-4-yl)-5-(tert-butylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(tert-butylsulfonylamino)pentanamide;5-(tert-butylsulfonylamino)-N-(9H-fluoren-1-yl)pentanamide;5-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]pentanamide;5-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]pentanamide;5-(tert-butylsulfonylamino)-N-(4-phenylphenyl)pentanamide;5-(tert-butylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(tert-butylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide is sourced from PubChem (CID 157498334), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).